Join to access to all OVN content. Join for Free
Gratitude: An absolute MUST for career advancement
gratitude in professional relationships career growth for MSLs compliance and gratitude expressing appreciation methods gratitude as career advancement tool

Gratitude: An absolute MUST for career advancement


Share This Article


Summary

In this special solo episode, Tom Caravela, Founder of The Carolan Group, delves into the essential role of gratitude within professional relationships and career growth for MSLs. He discusses the compliance aspects and the benefits of integrating gratitude into daily communications, emphasizing its impact on emails and post-meeting interactions. Tom shares creative methods for expressing appreciation and highlights annual gratitude practices to make it a consistent habit. Throughout the episode, he underscores gratitude as a crucial factor for career advancement, concluding with sincere appreciation for the listeners' support.

Tom Caravela discusses why gratitude is an absolute MUST for career advancement.

In this episode we discuss:

  • Good things come from gratitude
  • Connecting to people through gratitude
  • Time is currency
  • Going the extra mile to show others you appreciate them

Click for Source
gratitude in professional relationships, career growth for MSLs, compliance and gratitude, expressing appreciation methods, gratitude as career advancement tool

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Develop IDPs Individual Development Plans and Road Maps for Career Development
Partner Avatar MSL Talk: Tom Caravela, Elaine Nadeau

How to Develop IDPs Individual Development Plans and Road Maps for Career Development

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Explore OVN